Revenue
$21.8B
▲ 8.2% YoY
Net Income
$1.7B
▼ 1.6% YoY
EPS
$5.82
▼ 0.7% YoY
Cash
$641.0M
▼ 62.7% YoY
FY 2025 · As of 2025-09-30
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Garrison Michael David EVP & Pres Med.Essntl&BioPharm | Sell | Jun 10, 2026 | 1.1K | $151.48 | $167K | Form 4 ↗ |
Polen Thomas E Jr Chairman, CEO and President | Vest | Jun 1, 2026 | 20.2K | $126.16 | $2.55M | Form 4 ↗ |
Polen Thomas E Jr Chairman, CEO and President | Return | Jun 1, 2026 | 17.4K | $146.15 | $2.55M | Form 4 ↗ |
Polen Thomas E Jr Chairman, CEO and President | Sell | Jun 1, 2026 | 2.8K | $146.35 | $405K | Form 4 ↗ |
Menziuso Peter EVP and President, BDI | Grant | Jun 1, 2026 | 14.3K | $0.00 | $0 | Form 4 ↗ |
Feld Michael EVP, Chief Revenue Officer | Sell | May 26, 2026 | 75 | $147.35 | $11K | Form 4 ↗ |
Roque Vitor EVP & Chief Financial Officer | Grant | May 7, 2026 | 1.7K | $0.00 | $0 | Form 4 ↗ |
Feld Michael EVP, Chief Revenue Officer | Sell | Apr 27, 2026 | 74 | $151.94 | $11K | Form 4 ↗ |
Neal Shana Carol EVP and Chief People Officer | Sell tax | Apr 6, 2026 | 1.1K | $0.00 | $0 | Form 4 ↗ |
Feld Michael EVP, Chief Revenue Officer | Sell | Mar 26, 2026 | 75 | $156.83 | $12K | Form 4 ↗ |